MPN Expert Forum:Optimising Treatment in MF – 25th November 2023
Novartis, in collaboration with the Malaysian Society of Haematology, cordially invites you…….
Talks
EVOLVING TREATMENT PARADIGMS IN FIRST-LINE DLBCL: DECISION-MAKING AND PRACTICAL MANAGEMENT SYMPOSIUM – 30th SEPTEMBER 2023
Roche, in collaboration with MSH invites you. For registration, click on the link here: https://forms.gle/XR8t6gm9fgy38sJA7 For further inquiries, please contact : Ms. ONG Yi Theng @ +60122787455 Mail: yi_theng.ong@roche.com
STAMP Grand LAUNCH: First and Only STAMP inhibitor – 10th September 2023
Novartis, in collaboration with MSH cordially invites you..
Case Convensation: Optimizing Survival Outcomes for AML Patients – 15th July 2023
AbbVie Sdn Bhd, in collaboration with MSH, invites you.. For further details, please refer to the flyer for contact persons.
Malaysia Onco-Haem Summit 2023 – 1st July 2023
Johnson and Johnson Malaysia, in collaboration with Malaysian Society of Hematology cordially invites you. Name of event : Malaysia Oncology-Haematology Summit Date : 1 July 2023 Time : 2 pm – 7 pm Venue : Hilton Kuala Lumpur Programme Format Onco-Haem summit objectives: Haematology Track Objectives:
Expert Consensus For CLL Management In Asia – 25th May 2023
Astra Zeneca , in collaboration with MSH invites you. Please register to attend (For CPD point application) : https://astrazeneca.zoom.us/webinar/register/WN_eTY0lg74TfOpWi225TF-bA Please click this link to join the meeting: https://astrazeneca.zoom.us/s/96650367741?pwd=WUVKaWNqajBGNmlaTXd4TVJQeWZlZz09
Asian Leukemia Forum: Optimizing Treatment Strategies For Leukemia in Asia – 16th May 2023
AbbVie Sdn Bhd, in collaboration with MSH invites you: This is the registration link: https://event.on24.com/wcc/r/4190142/EAB1EACD6146BE2983E93C5E59875A03
Focussed Update on Current and Emerging Targeted Therapies in B-Cell Malignancies – 5th April 2023
BeiGene Singapore in collaboration with MSH invites you. Click HERE for registration. Date